Several leading In Vitro Diagnostic (IVD) companies have posted their first-quarter results for 2026, showing mixed performance across revenue, profitability, and cash flow.

It can be seen from analysis on major blood grouping analyzer-related patent applications published in the 3 years from 2018 to 2021 that benefited from the basically stable original technologies of the industry; domestic enterprises have continuously increased R&D inputs, constantly improved technical innovation capability, made breakthroughs in many technologies, and developed a batch of core components of instruments with independent intellectual property rights through follow-on R&D strategy.

Cardinal Health nixed its relationship with Suqian, China-based Siyang Holymed after learning that the FDA-authorized supplier had shifted production of Cardinal's surgical gowns to non-approved sites without the proper controlled environmen

Jabil Inc. is consolidating its healthcare businesses under Jabil Healthcare. These include Jabil’s embedded-sensors business, its injection molding business through Nypro, and its orthopedics, spine, trauma, and medical instruments operat

Researchers from Linköping University are behind a new study that has used artificial intelligence to investigate whether it is possible to discover biological networks using deep learning, in which entities known as "artificial neural netw

Abbott Laboratories has won CE mark for the new Gallant implantable cardioverter-defibrillator (ICD) and CRT-D devices. The Abbott Park, Il-based company received approval in Europe on the heels of ICD Week, a celebration of 40 years of the

Ares Genetics, a Curetis Group company, will collaborate with BGI Group to make molecular tests for coronavirus 2019-nCoV available in Europe.

China has been a large and ever-expanding market for Roche, driving much of the company's international growth, and this week, the firm said several initiatives and developments in that country keep it a crucial strategic market for its diag

Abcam said on Thursday that it has acquired the gene editing platform and oncology product portfolio of Applied StemCell for the research and diagnostic markets.

The US Food and Drug Administration late on Tuesday issued an emergency use authorization for a test from the US Centers for Disease Control and Prevention for the novel coronavirus, 2019-nCoV.

Roche on Thursday reported a 3 percent increase in sales of its diagnostics division in 2019, driven primarily by its immunodiagnostic solutions, which are part of its Centralized and Point of Care Solutions business.

Danaher reported on Thursday a 6 percent year-over-year increase in total sales for the fourth quarter, beating the consensus Wall Street estimate.